Actavalon – Actavalon is an oncology-focused company targeting two fundamental cancer pathways .

Actavalon is an oncology-focused company targeting two fundamental cancer pathways .

About Us
Business Development
Team
- Management Team
- Board of Directors
The Science
- Small Molecule p53 Modulators
- Selective Aryl Hydrocarbon Receptor Modulators (SAhRM)
Press
Contact Us

Contact Us

Welcome to Actavalon

Actavalon is an oncology-focused company targeting two fundamental cancer pathways - the p53 tumor suppressor pathway and the Aryl Hydrocarbon Receptor (AhR) pathway.

Contact Us

We are located in the JLABS incubator on the Johnson & Johnson Innovation Labs campus in San Diego, California.